UMass Amherst researchers have developed a groundbreaking nanoparticle-based cancer vaccine that prevented melanoma, ...
Nobel laureate Shimon Sakaguchi reflects on the role of regulatory T cells in peripheral immune tolerance and how the cells ...
In 2006 immunologist and 2025 Nobel prize winner Shimon Sakaguchi co-wrote an article in Scientific American that now feels ...
An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one ...
A team at Massachusetts General Hospital uncovered that an immune defense protein, Resistin-like molecule gamma, attacks ...
A special group of immune cells known as regulatory T cells, or Tregs for short, became an overnight sensation when a trio of ...
A vaccine designed to prevent and potentially treat triple-negative breast cancer is showing promise in human trials and ...
New research suggests a vitamin B3 supplement may prevent many cases of the world’s most frequently diagnosed cancer ...
Thousands could benefit from new genetic test for ‘incurable’ cancer - The disease is considered incurable and affects around 33,000 people in the UK ...
Vietnam Investment Review on MSN
Everest Medicines 2025: NMPA Green-Lights IND for Cancer Vaccine EVM14
First-in-human trials to start Q1 2026, giving biotech blogs EVM14 keywords and trial protocol. SHANGHAI, Oct. 13, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a ...
(NASDAQ:MRNA) today announced that clinical, safety and translational data from its Phase 1/2 study evaluating mRNA-4359 in ...
Mediafeed on MSN
Ozempic for weight loss: How it works, side effects & more
Ozempic has taken TikTok by storm. It’s hailed as a miracle weight loss drug that helps you shed the pounds without even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback